Screener
Eligibility screening
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of S…
Sponsored by Karuna Therapeutics, Inc., a Bristol Myers Squibb companyStudy detailsClinicalTrials.gov
79 US sites in AR, AZ, CA, FL +19
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.